Cart
sales@molnova.com
(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid
CAS No. 89667-39-0
(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid( —— )
Catalog No. M36939 CAS No. 89667-39-0
(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid is a derivative of 7-Phenyl-7-(3-Pyridyl) -6-Heptenoic Acid that can be used in biological research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 172 | In Stock |
|
| 10MG | 254 | In Stock |
|
| 25MG | 392 | In Stock |
|
| 50MG | 551 | In Stock |
|
| 100MG | 762 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid
-
NoteResearch use only, not for human use.
-
Brief Description(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid is a derivative of 7-Phenyl-7-(3-Pyridyl) -6-Heptenoic Acid that can be used in biological research.
-
Description(6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid is a derivative of 7-Phenyl-7-(3-Pyridyl) -6-Heptenoic Acid that can be used in biological research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number89667-39-0
-
Formula Weight281.35
-
Molecular FormulaC18H19NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=C/CCCCC(O)=O)(\C1=CC=CC=C1)/C=2C=CC=NC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sedanolide
Sedanolide is a natural phthalide first isolated from seed oil of the Umbelliferae family including celery.
-
Neuropeptide Y (29-6...
Neuropeptide Y (29-64), amide, human (TFA) is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.It is showed that Neuropeptide Y (29-64), amide, human (TFA) is able to protect cortical neurons from Aβ25-35 toxicity.
-
Amifostine trihydrat...
Amifostine is the first approved radioprotective drug, used to decrease the risk of kidney problems caused by treatment with cisplatin.
